What is RIVANNA?
RIVANNA® is a commercial-stage medical device innovator and manufacturer headquartered in Charlottesville, VA. The company is dedicated to developing and commercializing world-first, imaging-based medical technologies designed to elevate global standards of care. RIVANNA provides comprehensive imaging solutions for both early- and late-stage point-of-care spinal needle interventions and musculoskeletal diagnostics, positioning itself as a key player in the medical technology sector.
How much funding has RIVANNA raised?
RIVANNA has raised a total of $4.1M across 4 funding rounds:
Private Equity
$3M
Debt
$150K
Debt
$177K
Grant
$800K
Private Equity (2016): $3M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $177K supported by PPP
Grant (2025): $800K, investors not publicly disclosed
Key Investors in RIVANNA
PPP
Public-Private Partnership
What's next for RIVANNA?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and market expansion for RIVANNA. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the commercial reach of its innovative imaging solutions. RIVANNA's focus on point-of-care interventions and diagnostics suggests a strategic direction towards integrating advanced imaging directly into clinical workflows, potentially transforming patient care pathways.
See full RIVANNA company page
